BioNeutral Group, Inc., a chemical technology-based life science company focused on commercializing a combinational chemistry-based technology that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms, recently announced the company has retained the Chertoff Group to provide strategic advisory services.
Based in Washington, D.C. and led by former Secretary of Homeland Security Michael Chertoff, the Chertoff Group is a security and risk management advisory firm that counsels corporate and government clients addressing threats related to terrorism, fraud, cyber security, border protection and supply chain security. Under the terms of this agreement, the Chertoff Group will focus on making preliminary recommendations for BioNeutral’s proprietary chemical technology for potential use in commercial and government health, defense and bio security markets in the United States.
Stephen J. Browand, president and chief executive officer of BioNeutral Group, Inc., stated, “We are excited to engage former Secretary Chertoff and his firm to assist us in our endeavors; presenting our proprietary technology to the various markets including health, defense and bio security.” He continued, “It is a privilege to have such an elite group represent our company and we are confident that they will play a significant role in the successful strategic introduction of our life-saving technology.”
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Stock Report http://video.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment